We’re experiencing issues for some mobile devices with our ARTG dataset filter function. We apologise for any inconvenience while we work to fix this.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advertising (292)
- COVID-19 (164)
- Safety monitoring and information (120)
- Compliance and enforcement (93)
- Legislation (78)
- Manufacturing (60)
- Vaping hub (57)
- Labelling and packaging (43)
- Import and export (38)
- Medicinal cannabis hub (28)
- Scheduling (national classification system) (27)
- Sunscreens (20)
- Weight loss products (18)
- Shortages and supply disruptions (11)
- Committees and advisory bodies (9)
- Cosmetics (6)
- Unique Device Identification (UDI) hub (5)
- Clinical trials (3)
- Fees and payments (2)
- Prescription opioids hub (2)
- Urogynaecological (transvaginal) surgical mesh hub (2)
- Breast implant hub (1)
Search
1294 result(s) found, displaying 901 to 925
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines
-
Regulatory decision noticesThe Therapeutic Goods (Permissible Ingredients) Determination has been updated.
-
Media releasesThe TGA has issued two infringement notices to Perth-based company Bajaria Global Pty Ltd
-
Media releasesThe TGA has issued four infringement notices for the alleged unlawful importation of infrared thermometers, rigid strapping tapes and iodine prep pads.
-
News articlesInvitation to the National Measurement Institute's mask/respirator testing forum.
-
Media releasesFederal Court finds Evolution Supplements Australia breached advertising laws
-
Media releasesThe TGA has granted provisional approval to AstraZeneca Pty Ltd for its COVID-19 vaccine
-
Regulatory decision noticesThis labelling exemption is granted under section 1.5.5 of Part 2 of the current Poisons Standard.
-
Media releasesAustralia, through the TGA, is one of only five non-European Union regulators formally invited to participate by the European Medicines Agency (EMA)
-
Regulatory decision noticesMr Leyonhjelm was directed to cease advertising a prescription medicine for the treatment of Covid-19.
-
Media releasesThe TGA has concluded that there is no specific risk of vaccination with the Pfizer-BioNTech COVID-19 vaccine in elderly patients.
-
News articlesTherapeutic Goods (Medical Devices - Face Masks and Other Articles) (COVID-19 Emergency) Exemption 2020 ceases on 31 January 2021.
-
Media releasesThe TGA has issued eight infringement notices to Sydney-based company for allegedly failing to provide information and face mask samples to the TGA when required to do so, and for providing false and misleading information.
-
News articlesUpdated to include new section on Reprocessing of PPE by Healthcare facilities
-
News articlesHealthcare professionals and public health authorities will have a central role in discussing vaccination against COVID-19 with their patients.
-
Regulatory decision noticesThe Therapeutic Goods (Permissible Indications) Determination has been updated
-
News articlesThe TGA has granted a provisional determination to Biocelect Pty Ltd (on behalf of Novavax Inc.) in relation to the COVID-19 Vaccine, NVX-CoV2373.
-
Media releasesIn recent days the TGA has received reports of about 30 deaths in over 40,000 elderly individuals in Norway vaccinated with the Pfizer BioNTech vaccine
-
Media releasesThe TGA has issued an infringement notice to Brisbane-based company PPE Direct Pty Ltd, trading as Infinity Biotech for the alleged unlawful advertising of a COVID-19 Rapid Test kit under the Therapeutic Goods Act 1989.
-
Media releasesThe TGA has issued an infringement notice to Melbourne-based company Enviro Tech Holdings Pty Ltd for the alleged unlawful importation of surgical face masks in relation to COVID-19.
-
News articlesThe TGA is warning consumers that off-label use of so-called smart drugs, such as Modafinil, is not a wise choice.
-
Media releasesFrom 1 October 2021, the law for consumers to import nicotine e-cigarettes and liquid nicotine will align with the law for them to buy such products domestically
-
News articlesThe Regulation Impact Statement (RIS) and the regulatory burden costing have been published alongside the delegate's final decision on the scheduling of nicotine.
-
Media releasesThe TGA has issued three infringement notices to a Sydney man for the alleged unlawful advertising of a disinfectant and a hand sanitiser in relation to COVID-19
-
Media releasesThe TGA has issued four infringement notices totalling $10,656 to a West Australian man, for alleged unlawful advertising of cannabidiol (CBD)